ID: | F25 | |
---|---|---|
Name: | Nadolol | |
Description: | ||
Labels: | ||
CAS: | 42200-33-9 | |
InChi Code: | InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1 |
Class_pH3: Class of membrane permeability at pH 3 i
Value | Source or prediction |
---|---|
L |
M1: Model at pH 3 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M7: Model at pH 3 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_pH5: Class of membrane permeability at pH 5 i
Value | Source or prediction |
---|---|
L |
M2: Model at pH 5 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M8: Model at pH 5 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_pH7.4: Class of membrane permeability at pH 7.4 i
Value | Source or prediction |
---|---|
L |
M3: Model at pH 7.4 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M9: Model at pH 7.4 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_pH9: Class of membrane permeability at pH 9 i
Value | Source or prediction |
---|---|
L |
M4: Model at pH 9 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M10: Model at pH 9 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_highest: Class of highest membrane permeability for pH range 3 to 9 i
Value | Source or prediction |
---|---|
L |
M5: Model for highest membrane permeability with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M11: Model for highest membrane permeability with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_logPo: Class of intrinsic membrane permeability i
Value | Source or prediction |
---|---|
L |
M6: Model for intrinsic membrane permeability (logPo) with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M12: Model for intrinsic membrane permeability (logPo) with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_FDA: BCS permeability class for FDA reference drugs i
Value | Source or prediction |
---|---|
L |
experimental value |
L |
Fig5_1: Decision tree based on models with hydrophobicity descriptors (FDA reference drugs for BCS permeability class) |
L |
Fig5_2: Decision tree based on the models with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Link | Resource description |
---|---|
DTXSID3023342 | US EPA CompTox Dashboard |